Clinical and Biological significance of MYC/BCL6 dual gene rearrangements and protein co-expression in de novo diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program

Qinng Ye, Ken H. Young, Shimin Hu et al.|Clinical Lymphoma Myeloma & Leukemia|2015

Cited by 0